Sweden· SE-20090111000024
Revolade 50 mg Filmdragerad tablett
A medicinal product containing eltrombopag, registered in Sweden by Novartis Europharm Limited.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Eltrombopag
- Manufacturer
- Novartis Europharm Limited
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20090111000024
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Eltrombopag in 11 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- NetherlandsEltrombopag Abdi 50 mg filmomhulde tablettenAbdi Farma GmbH
- SpainELTROMBOPAG ACCORD 50 MG COMPRIMIDOS RECUBIERTOS CON PELICULA EFGAccord Healthcare S.L.U.
- SwitzerlandEltrombopag Accord
- PolandEltrombopag AccordAccord Healthcare S.L.U.
- NorwayEltrombopag AccordAccord Healthcare S.L.U.
- IrelandEltrombopag Krka 50 mg film-coated tabletsKRKA, d.d., Novo mesto
- United StatesELTROMBOPAGCamber Pharmaceuticals, Inc.
- United KingdomEltrombopag 25mg tabletsPerennial Pharma Ltd
Authorised across Europe · EMA
The same active substance is authorised in 29 EEA countries. Names it is sold under:
- Austria · Elrevolan, Eltrombopag +pharma
- Belgium · Eltrombopag Krka
- Bulgaria · Eltrombopag Pharmascience, Eltrombopag Pharmdedict
- Cyprus · Eltrombopag Msn, Eltrombopag Sandoz
- Czechia · Eltrombopag Abdi, Eltrombopag Krka
- Germany · Eltrombopag 1 A Pharma, Eltrombopag Abdi
- Denmark · Eltrombopag Glenmark, Eltrombopag Krka
- Estonia · Eltrombopag Krka, Eltrombopag Msn
- Spain · Eltrombgopa Glenmark, Eltrombopag Aurovitas Spain
- Finland · Eltrombopag Avansor, Eltrombopag Krka
- France · Eltrombopag Biogaran, Eltrombopag Eg
- United Kingdom (Northern Ireland) · Eltrombopag Abdi, Eltrombopag Accord
- Greece · Eltrombopag Anabiosis, Eltrombopag Faran
- Croatia · Eltrombopag Alpha-Medical, Eltrombopag Msn
- Hungary · Elrevolan, Eltrombopag Elpen
- Ireland · Eltrombopag Clonmel, Eltrombopag Krka
- Iceland · Eltrombopag Accord, Eltrombopag Coripharma
- Italy · Elrevolan, Eltrombopag Abdi
- Liechtenstein · Eltrombopag Accord, Eltrombopag Viatris
- Lithuania · Eltrombopag Krka, Eltrombopag Msn
- Latvia · Eltrombopag Krka, Eltrombopag Olpha
- Malta · Eltrombopag Aspen, Eltrombopag Clonmel
- Netherlands · Eltrombopag Abdi, Eltrombopag Amarox
- Norway · Eltrombopag Accord, Eltrombopag Glenmark
- Poland · Eltrombopag Glenmark, Eltrombopag Krka
- Portugal · Eltrombopag Bluepharma, Eltrombopag Cipla
- Romania · Eltrombopag Dr. Reddy’s, Eltrombopag Msn
- Slovenia · Eltrombopag Krka, Eltrombopag Msn
- Slovakia · Eltrombopag Glenmark, Eltrombopag Krka
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/f888e46f-5fab-463c-8a32-380c5e87b3ad GET /v1/drugs/f888e46f-5fab-463c-8a32-380c5e87b3ad?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EMA",
"EPAR"
],
"se_npl_id": "20090111000024",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20090111000024",
"product_doc_link": "https://www.ema.europa.eu/en/medicines/human/EPAR/revolade"
}See everything about eltrombopag.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.